Kineta Inc (NASDAQ:KA)
| 3.32 Delayed Data As of Mar 31 |  -0.03 / -0.90%Today’s Change | 2.87 Today|||52-Week Range 15.54 | -47.72% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $62.6M |
Company Description
Kineta, Inc. is a clinical-stage biotechnology company, which develops immunotherapies for cancer patients. Its immuno-oncology focused platform aims at developing fully human antibodies to address the major mechanisms of cancer immune resistance. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA.
Contact Information
Kineta, Inc. 219 Terry Avenue North Seattle Washington 98109 |
Employees
Shareholders
| Individual stakeholders | 8.48% |
| Mutual fund holders | 2.02% |
| Other institutional | 1.82% |
Top Executives
| Shawn P. Iadonato | Chief Executive Officer & Director |
| Craig W. Philips | President |
| Keith Baker | Chief Financial Officer |
| Thierry Guillaudeux | Chief Scientific Officer |
| Jacques Bouchy | EVP-Investor Relations & Business Development |
